The contractor shall assist niaid in the planning and implementation of a consultation for niaid contractors and extramural programmatic staff. The consultation shall address capa and deviation…
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $82,905
Award facts
- Opportunity
-
- 75N93022F00001 Solicitation number
- Contract value 100% obligated
- $82,905.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $82,905 |
About this award
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, with a ceiling value of $82,905.00, is to assist NIAID in planning and implementing a consultation for NIAID contractors and extramural programmatic staff to address Corrective and Preventive Action (CAPA) and deviation management for preclinical and nonclinical research. The contract is a delivery order under the larger HIV Microbicides and Biomedical Prevention 2016-2021 Indefinite Delivery Vehicle, and has a performance period through May 31, 2023. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants, particularly from NIH and HHS, to advance the development of medical countermeasures for various infectious diseases and other health conditions.
Description
The contractor shall assist niaid in the planning and implementation of a consultation for niaid contractors and extramural programmatic staff. The consultation shall address capa and deviation management for preclinical and nonclinical research.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $82,905 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award